Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the ...
Today, we're discussing novel therapies in cardiorenal metabolic syndrome, focusing in on the mineralocorticoid receptor antagonists and potassium binders. I'm absolutely delighted to have two expert ...